CD1-MR1 2015* Olivier Gasser
Malaghan Institute of Medical Research, NZ, New Zealand
- This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:
An NKT cell-activating glycolipid-peptide conjugate vaccine enhances human anti-viral CD8+ T cell responses (#84)
4:00 PM
Astrid Authier-Hall
Poster Listing
A phase I dose escalation trial of immunisation with autologous dendritic cells pulsed with NY-ESO-1 peptide and α-galactosylceramide in patients with high-risk surgically resected stage II, III or IV melanoma (#100)
4:00 PM
Olivier Gasser
Poster Listing